Thermo Fisher Scientific Partners with the CDC to Accelerate Global Microbial Identification
New software connects public health laboratories with MicrobeNet database to advance infectious disease surveillance
New software connects public health laboratories with MicrobeNet database to advance infectious disease surveillance
therascreen® EGFR RGQ PCR Kit to guide treatment with AstraZeneca’s lung cancer drug in U.S.
Advances in biomarker research using Droplet Digital™ PCR
An experimental cystic fibrosis drug has been shown to prevent the disease’s damage to the liver, thanks to a world-first where scientists grew mini bile ducts in the lab.
Study in Nature Communications identifies new predictors of patient outcome and suggests targeted therapy approaches may benefit more patients than previously thought.
Work conducted at Center to revolutionize diagnosis and treatment of cancer globally, selects Thermo Fisher Scientific as technology partner
Initial focus will be multiplex assays for infectious diseases on flagship automation platform
Discover the lab instruments Dr Parrington couldn't do his research without
Improving monoclonal gammopathy diagnosis
The expanded collaboration will focus on developing immuno-oncology mouse models and other disease-specific experimental models supporting translational medical research
Field validation study published in Lancet confirms ReEBOV point-of-care Ebola test accuracy with 100% sensitivity, 92% specificity
Report identifies need for improved assays across numerous disease areas and more education around LC-MS/MS technologies
Unique capillary design optimizes sensitivity and minimizes carryover for high performance protein identification
The five most reviewed diagnostic products on SelectScience